STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/303% below fair value
$253.44−2.83 (-1.10%)
Close on Nov 12, 2026Market cap $24.71BP/E 30.1Yield 0.97%
Steris total assets
Total assets on the balance sheet at the end of each period.
Steris's total assets was $10.71B at Sep 30, 2026. For fiscal 2026 it was $10.74B, up 5.8% from the year before. The highest annual figure on record is $11.42B in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $10.74B | +5.8% |
| FY2025 | Mar 31, 2025 | $10.15B | -8.3% |
| FY2024 | Mar 31, 2024 | $11.06B | +2.2% |
| FY2023 | Mar 31, 2023 | $10.82B | -5.3% |
| FY2022 | Mar 31, 2022 | $11.42B | +73.8% |
| FY2021 | Mar 31, 2021 | $6.57B | +20.8% |
| FY2020 | Mar 31, 2020 | $5.44B | +7.2% |
| FY2019 | Mar 31, 2019 | $5.07B | -2.4% |
| FY2018 | Mar 31, 2018 | $5.20B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $10.71B | +2.9% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $10.74B | +3.2% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $10.74B | +5.8% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $10.59B | +5.8% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $10.41B | +1.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $10.41B | +2.9% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $10.15B | -8.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $10.01B | -12.5% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $10.24B | -9.2% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $10.11B | -6.3% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $11.06B | +2.2% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $11.44B | +5.9% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $11.28B | +7.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $10.78B | -3.6% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $10.82B | -5.3% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $10.80B | -7.6% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $10.49B | -10.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $11.19B | -7.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $11.42B | +73.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $11.69B | +77.6% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $11.75B | +114.0% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $12.10B | +125.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $6.57B | +20.8% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $6.58B | +23.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $5.49B | +5.9% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $5.36B | +2.6% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $5.44B | +7.2% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $5.34B | +2.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $5.19B | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $5.23B | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $5.07B | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $5.20B | – |
See a number that looks wrong?